ArticleHistochemistry and cell biology2026
Deletion of Cipc promotes regenerative myogenesis in mdx mice and is associated with increased myogenin expression.
Article in Histochemistry and cell biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Skeletal muscle regeneration depends on satellite cells, which proliferate, differentiate, and fuse to repair damaged myofibers. Satellite-cell dysfunction contributes to defective regeneration in Duchenne muscular dystrophy (DMD), but the contribution of circadian regulators to this process remains incompletely understood. Here, we investigated the role of the CLOCK-interacting protein CIPC in satellite-cell differentiation and muscle regeneration in mdx mice. Satellite cell-specific deletion of Cipc increased centrally nucleated fibers and embryonic myosin heavy chain-positive regenerating fibers in dystrophic and ischemia-reperfusion-injured tibialis anterior muscles, and enhanced MyHC-positive myotube formation in primary cultures. Cipc deletion was accompanied by increased MyoD and myogenin mRNA expression and a higher number of myogenin-positive cells. RNA sequencing of day-3 differentiated satellite cells identified Mapk14/p38α and Elk1 as candidate upstream regulators associated with increased myogenin expression. Immunoblotting in three independent experiments further showed increased p38 and ELK-1 phosphorylation in Cipc-deficient satellite cells, without an apparent genotype-dependent change in total p38 or total ELK-1 abundance. These findings indicate that Cipc deletion enhances regenerative myogenesis in mdx mice and is associated with increased p38/ELK-1 signaling and myogenin expression. Because pathway inhibition, ELK-1 promoter-occupancy, and myogenin loss-of-function experiments were not performed, the p38/ELK-1-myogenin axis should be regarded as a candidate mechanism rather than an established causal pathway.
Indexed as
Identifiers
42825803What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.